Roles of USP9X in cellular functions and tumorigenesis (Review)

被引：10
|
作者：
Meng, Yimei [1 ]
Hong, Chaojin [1 ]
Yang, Sifu [1 ]
Qin, Zhiquan [1 ]
Yang, Liu [1 ,2 ]
Huang, Yumei [1 ,2 ]
机构：
[1] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Dept Med Oncol, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Dept Med Oncol, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
来源：
ONCOLOGY LETTERS | 2023年 / 26卷 / 06期
关键词：
ubiquitin-specific peptidase 9X; cancer; deubiquitinase; post-translational modification; therapeutic target; LUNG-CANCER CELLS; DEUBIQUITINASE USP9X; FAT-FACETS; DEUBIQUITYLATING ENZYME; IN-VIVO; EXPRESSION ANALYSIS; PROTEIN; INHIBITION; DEGRADATION; SUPPRESSES;
D O I：
10.3892/ol.2023.14093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ubiquitin-specific peptidase 9X (USP9X) is involved in certain human diseases, including malignancies, atherosclerosis and certain diseases of the nervous system. USP9X promotes the deubiquitination and stabilization of diverse substrates, thereby exerting a versatile range of effects on pathological and physiological processes. USP9X serves vital roles in the processes of cell survival, invasion and migration in various types of cancer. The present review aims to highlight the current knowledge of USP9X in terms of its structure and the possible mediatory mechanisms involved in certain types of cancer, providing a thorough introduction to its biological functions in carcinogenesis and further outlining its oncogenic or suppressive properties in a diverse range of cancer types. Finally, several perspectives regarding USP9X-targeted pharmacological therapeutics in cancer development are discussed.
引用
收藏
页数：14
相关论文
共 50 条
  • [1] Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment
    Gao, Hongli
    Chen, Zhiguang
    Zhao, Liang
    Ji, Ce
    Xing, Fei
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [2] La FAM fatale: USP9X in development and disease
    Murtaza, Mariyam
    Jolly, Lachlan A.
    Gecz, Jozef
    Wood, Stephen A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (11) : 2075 - 2089
  • [3] A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer
    Chen, Xiangling
    Yu, Chengli
    Gao, Jing
    Zhu, Hongwen
    Cui, Binghai
    Zhang, Tao
    Zhou, Yanting
    Liu, Qian
    He, Han
    Xiao, Ruoxuan
    Huang, Ruimin
    Xie, Hua
    Gao, Daming
    Zhou, Hu
    THERANOSTICS, 2018, 8 (09): : 2348 - 2360
  • [4] Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis
    Wang, Biqing
    Tang, Xuening
    Yao, Liu
    Wang, Yuxin
    Chen, Zhipeng
    Li, Mengqi
    Wu, Naishi
    Wu, Dawei
    Dai, Xiangchen
    Jiang, Hongfeng
    Al, Ding
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (10)
  • [5] Mutations in USP9X Are Associated with X-Linked Intellectual Disability and Disrupt Neuronal Cell Migration and Growth
    Homan, Claire C.
    Kumar, Raman
    Nguyen, Lam Son
    Haan, Eric
    Raymond, F. Lucy
    Abidi, Fatima
    Raynaud, Martine
    Schwartz, Charles E.
    Wood, Stephen A.
    Gecz, Jozef
    Jolly, Lachlan A.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2014, 94 (03) : 470 - 478
  • [6] The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
    Perez-Mancera, Pedro A.
    Rust, Alistair G.
    van der Weyden, Louise
    Kristiansen, Glen
    Li, Allen
    Sarver, Aaron L.
    Silverstein, Kevin A. T.
    Gruetzmann, Robert
    Aust, Daniela
    Ruemmele, Petra
    Knoesel, Thomas
    Herd, Colin
    Stemple, Derek L.
    Kettleborough, Ross
    Brosnan, Jacqueline A.
    Li, Ang
    Morgan, Richard
    Knight, Spencer
    Yu, Jun
    Stegeman, Shane
    Collier, Lara S.
    ten Hoeve, Jelle J.
    de Ridder, Jeroen
    Klein, Alison P.
    Goggins, Michael
    Hruban, Ralph H.
    Chang, David K.
    Biankin, Andrew V.
    Grimmond, Sean M.
    Wessels, Lodewyk F. A.
    Wood, Stephen A.
    Iacobuzio-Donahue, Christine A.
    Pilarsky, Christian
    Largaespada, David A.
    Adams, David J.
    Tuveson, David A.
    NATURE, 2012, 486 (7402) : 266 - +
  • [7] USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells
    Lu, Qin
    Zhang, Fang-Lin
    Lu, Da-Yun
    Shao, Zhi-Ming
    Li, Da-Qiang
    CANCER MEDICINE, 2019, 8 (15): : 6730 - 6740
  • [8] La FAM fatale: USP9X in development and disease
    Mariyam Murtaza
    Lachlan A. Jolly
    Jozef Gecz
    Stephen A. Wood
    Cellular and Molecular Life Sciences, 2015, 72 : 2075 - 2089
  • [9] The X-linked deubiquitinase USP9X is an integral component of centrosome
    Wang, Qian
    Tang, Yiman
    Xu, Yue
    Xu, Shilei
    Jiang, Yong
    Dong, Qiuping
    Zhou, Yongsheng
    Ge, Wenshu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (31) : 12874 - 12884
  • [10] Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
    Hung Thanh Nguyen
    Andrejeva, Diana
    Gupta, Rajat
    Choudhary, Chunaram
    Hong, Xin
    Eichhorn, Pieter J. A.
    Loya, Anand C.
    Cohen, Stephen M.
    CELL DISCOVERY, 2016, 2
12345